Selegiline Patch for Treatment of Nicotine Dependence

Not Recruiting

Trial ID: NCT01330030

Age - 18 Years-65 Years Gender - All Accepting Healthy Volunteers - yes

Purpose

Relapse to smoking is a common problem affecting smokers who seek treatment. The purpose of this study is examine whether selegiline, given in the form of a skin patch, is effective in stopping smoking.

Official Title

Selegiline Patch for Treatment of Nicotine Dependence

Stanford Investigator(s)

Joel Killen

Eligibility


Inclusion Criteria:

   - Smokes greater than 20 cigarettes per day

Exclusion Criteria:

   - History of Parkinson's disease, high blood pressure, or severe liver or kidney disease

   - Current substance abuse

   - Mental illness

   - Skin conditions that could interfere with patch use

   - Using antidepressant medications (e.g., levodopa/carbidopa, methyldopa, or any MAO
   inhibitor)

   - Pregnant or breastfeeding

View More
View Less

Intervention(s):

other: matching placebo

drug: Selegiline

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Joel Killen
6507259443

©2024 Stanford Medicine